Mihyang Ha

Mihyang Ha

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in OncoImmunology
Verified
Journal Article
Open access
YKYeongjoo Kim
Yeongjoo Kim
JKJi Wan Kang
Ji Wan Kang
JKJunho Kang
Junho Kang
EKEun Jung Kwon
Eun Jung Kwon
MHMihyang Ha
Mihyang Ha
YKYun Hak Kim
Yun Hak Kim
The tumor microenvironment (TME) within mucosal neoplastic tissue in oral cancer (ORCA) is greatly influenced by tumor-infiltrating lymphocytes (TILs). Here, a clustering method was performed using CIBERSORT profiles of ORCA data that were filtered from the publicly accessible data of patients with head and neck cancer in The Cancer Genome Atlas (TCGA) using hierarchical clustering where patients were regrouped into binary risk groups based on the clustering-measuring scores and survival patterns associated with individual groups. Based on this analysis, clinically reasonable differences were identified in 16 out of 22 TIL fractions between groups. A deep neural network classifier was trained using the TIL fraction patterns. This internally validated classifier was used on another individual ORCA dataset from the International Cancer Genome Consortium data portal, and patient survival patterns were precisely predicted. Seven common differentially expressed genes between the two risk groups were obtained. This new approach confirms the importance of TILs in the TME and provides a direction for the use of a novel deep-learning approach for cancer prognosis.

1 January 2018 in Annals of Hepato-Biliary-Pancreatic Surgery
Verified
Journal Article
Open access
PDF file
SCSung Hwan Cho
Sung Hwan Cho
MHMihyang Ha
Mihyang Ha
YCYong-Hoon Cho
Yong-Hoon Cho
JRJe Ho Ryu
Je Ho Ryu
KYKwangho Yang
Kwangho Yang
YKYun Hak Kim
Yun Hak Kim
Cho SH, et al. Ann Hepatobiliary Pancreat Surg. 2018 Nov;22(4):305-309. https://doi.org/10.14701/ahbps.2018.22.4.305

6 October 2020 in Critical Care
Verified
Journal Article
Open access
PDF file
HYHye Ju Yeo
Hye Ju Yeo
DKDohyung Kim
Dohyung Kim
MHMihyang Ha
Mihyang Ha
HJHyung Gon Je
Hyung Gon Je
JKJeong Soo Kim
Jeong Soo Kim
WCWoo Hyun Cho
Woo Hyun Cho
Background: Although the prevention of extracorporeal membrane oxygenation (ECMO) catheter-related infection is crucial, scientific evidence regarding best practices are still lacking. Methods: We conducted an uncontrolled before-and-after study to test whether the introduction of disinfection with 2% chlorhexidine gluconate (CHG) and 70% isopropyl alcohol (IPA) of the exposed circuits and hub in patients treated with ECMO would affect the rate of blood stream infection (BSI) and microbial colonization of the ECMO catheter. We compared the microbiological and clinical data before and after the intervention. Results: A total of 1740 ECMO catheter days in 192 patients were studied. These were divided into 855 ECMO catheter days in 96 patients before and 885 ECMO catheter days in 96 patients during the intervention. The rates of BSI were significantly decreased during the intervention period at 11.7/1000 ECMO catheter days before vs. 2.3/1000 ECMO catheter days during (difference 9.4, 95% confidence interval (CI) 1.5–17.3, p = 0.019). Furthermore, the colonization of the ECMO catheter was similarly significantly reduced during the intervention period at 10.5/1000 ECMO catheter days before vs. 2.3/1000 ECMO catheter days during intervention (difference 8.3, 95% CI 0.7–15.8, p = 0.032). Hospital mortality (41.7% vs. 24%, p = 0.009) and sepsis-related death (17.7% vs. 6.3%, p = 0.014) were also significantly decreased during intervention. Conclusion: Extensive disinfection of exposed ECMO circuits and hub with 2% CHG/IPA was associated with a reduction in both BSI and microbial colonization of ECMO catheters. A further randomized controlled study is required to verify these results. Trial registration: KCT 0004431

11 September 2018 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
MHMihyang Ha
Mihyang Ha
MHMyoung‐Eun Han
Myoung‐Eun Han
JKJi‐Young Kim
Ji‐Young Kim
DJDae Cheon Jeong
Dae Cheon Jeong
SOSae-Ock Oh
Sae-Ock Oh
YKYun Hak Kim
Yun Hak Kim

1 February 2019
Verified
Journal Article
Closed access
MHM. Ha
M. Ha
YSY. R. Son
Y. R. Son
JKJ. Kim
J. Kim
SPS. M. Park
S. M. Park
CHC. M. Hong
C. M. Hong
YKYun Hak Kim
Yun Hak Kim

17 April 2019 in Frontiers in Genetics
Verified
Journal Article
Open access
PDF file
MHMihyang Ha
Mihyang Ha
HMHwan Moon
Hwan Moon
DCDongwook Choi
Dongwook Choi
WKWonmo Kang
Wonmo Kang
JKJi-Hong Kim
Ji-Hong Kim
DLDongjun Lee 
Dongjun Lee 
Transmembrane p24 trafficking protein 3 (TMED3) is a metastatic suppressor in colon cancer and hepatocellular carcinoma. However, its function in the progression of clear cell renal cell carcinoma (ccRCC) is unknown. Here, we report that TMED3 could be a new prognostic marker for ccRCC. Patient data were extracted from cohorts in the Cancer Genome Atlas (TCGA) and the International Cancer Genome Consortium (ICGC). Differential expression of TMED3 was observed between the low stage (Stage I and II) and high stage (Stage III and IV) patients in the TCGA and ICGC cohorts and between the low grade (Grade I and II) and high grade (Grade III and IV) patients in the TCGA cohort. Further, we evaluated TMED3 expression as a prognostic gene using Kaplan-Meier survival analysis, multivariate analysis, the time-dependent area under the curve (AUC) of Uno’s C-index, and the AUC of the receiver operating characteristics at 5 years. The Kaplan-Meier analysis revealed that TMED3 overexpression was associated with poor prognosis for ccRCC patients. Analysis of the C-indices and area under the receiver operating characteristic curve further supported this. Multivariate analysis confirmed the prognostic significance of TMED3 expression levels (P = 0.005 and 0.006 for TCGA and ICGC, respectively). Taken together, these findings demonstrate that TMED3 is a potential prognostic factor for ccRCC.